15-Epi-lipoxin A4 inhibits the progression of endometriosis in a murine model

Fertility and Sterility

Volumn 93, Issue 5, 2010, Pages 1440-1447

  Chen, Qiong Hua ^a,b   Zhou, Wei Dong ^c   Pu, De Min ^a   Huang, Qian Sheng ^c   Li, Tian ^a   Chen, Qing Xi ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Endometriosis; LXA4; MMP 2; MMP 9; Murine model

Indexed keywords

GELATINASE A; GELATINASE B; LIPOXIN A; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INHIBITION KINETICS; MOUSE; NONHUMAN; PERITONEAL FLUID; PERITONEUM CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; ZYMOGRAPHY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASCITIC FLUID; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOWN-REGULATION; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRUS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INJECTIONS, INTRAPERITONEAL; LIPOXINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77949264953     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.01.107     Document Type: Article

References (34)

1. Kyama C.M., Overbergh L., Mihalyi A., Meuleman C., Mwenda J.M., Mathieu C., et al. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril 89 (2008) 301-310
2. Dogan E., Saygili U., and Posaci{dotless} C. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertil Steril 82 (2004) 1115-1120
3. Li Y.G., Pu D.M., and Li Y.L. The expression of cyclooxygenase-2 in cervical cancers and Hela cells was regulated by estrogen/progestogen. J Huazhong Univ Sci Technol 27 (2007) 457-460
4. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., and Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5 (1999) 698-701
5. Graham D.J., Campen D., Hui R., Spence M., Cheetham C., Levy G., et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365 (2005) 475-481
6. Bresalier R.S., Sandler R.S., Quan H., Bolognese J.A., Oxenius B., Horgan K., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352 (2005) 1092-1102
7. Gilroy D.W., Lawrence T., Perretti M., and Rossi A.G. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3 (2004) 401-416
8. Serhan C.N., and Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 6 (2005) 1191-1197
9. Serhan C.N. Endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25 (2007) 101-137
10. Motohashi E., Kawauchi H., Endo H., Kondo H., Kitasato H., Kuramoto H., et al. Regulatory expression of lipoxinA4 receptor in physiologically estruscycle and pathologically endometriosis. Biomed Pharmacother 59 (2005) 330-338
11. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6 (1990) 121-125
12. Chen Q.H., Qu J.Y., Xu Y.Y., Qiu N.X., Zhuang Y.Z., Zhong S., et al. Expressions of matrix metalloproteinase-9 and tissue inhibitorof metalloproteinase-1 in ectopic and eutopic endometrium. Chin J Obstet Gynecol 39 (2004) 809-812
13. Li T., Li Y.G., and Pu D.M. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest 62 (2006) 229-235
14. Mott J.D., and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16 (2004) 558-564
15. Luttikhuizen D.T., Van Amerongen M.J., De Feijter P.C., Petersen A.H., Harmsen M.C., and Van Luyn M.J. The correlation between difference in foreign body reaction between implant locations and cytokine and MMP expression. Biomaterials 27 (2006) 5763-5770
16. Dabrosin C., Gyorffy S., Margetts P., Ross C., and Gauldie J. Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. Am J Pathol 161 (2002) 909-918
17. Cao Z.Y. Chinese obstetrics and gynecology. In: Gao Y. (Ed). The pathology of endometriosis Vol. 2 (2004), People's Health Publishing House, Beijing 1486-1488
18. -ΔΔCT method. Methods 25 (2001) 402-408
19. Rugh R. The mouse: its reproduction and development (1990), Oxford University, New York
20. Becker C.M., Sampson D.A., Rupnick M.A., Rohan R.M., Efstathiou J.A., Short S.M., et al. Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. Fertil Steril 84 (2005) 1144-1155
21. Hughes E., Brown J., Collins J.J., Farquhar C., Fedorkow D.M., and Vandekerckhove P. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 18 (2007) CD000155
22. Olivares C., Bilotas M., Buquet R., Borghi M., Sueldo C., Tesone M., et al. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Hum Reprod 23 (2008) 2701-2708
23. Majno G. The healing hand: man and wound in the ancient world (1991), Harvard University Press, Cambridge, MA
24. Levy B.D., Clish C.B., Schmidt B., Gronert K., and Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2 (2001) 612-619
25. Haworth O., and Buckley D.C. Resolving the problem of persistence in the switch from acute to chronic inflammation. Proc Natl Acad Sci USA 104 (2007) 20647-20684
26. Schwab J.M., Nan C., Makoto A., and Serhan C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447 (2007) 869-874
27. Serhan C.N., Yacoubian S., and Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 3 (2008) 279-312
28. Serhan C.N., Chiang N., and Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8 (2008) 349-361
29. Opdenakker G., Van den Steen P.E., Dubois B., Nelissen I., Van Coillie E., Masure S., et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69 (2001) 851-859
30. Mulayim N., Savlu A., Guzeloglu-Kayisli O., Kayisli U.A., and Arici A. Regulation of endometrial stromal cell matrix metalloproteinase activity and invasiveness by interleukin-8. Fertil Steril 81 (2004) 904-911
31. Sodin-Semrl S., Taddeo B., Tseng D., Varga J., and Fiore S. Lipoxin A4 inhibits IL-1β-induced IL-6, IL-8 and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 164 (2000) 2660-2666
32. Deura I., Harada T., Taniguchi F., Iwabe T., Izawa M., and Terakawa N. Reduction of estrogen production by interleukin-6 in a human granulosa tumor cell line may have implications for endometriosis-associated infertility. Fertil Steril 83 (2005) 1086-1092
33. Di Carlo C, Bonifacio M, Tommaselli GA, Bifulco G, Guerra G, Nappi C. Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium. Fertil Steril (in press).
34. Gilabert-Estellés J., Ramón L.A., España F., Gilabert J., Vila V., Réganon E., et al. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 22 (2007) 2120-2127